TP53 and non-small cell lung carcinoma: In this study, higher frequency of TP53 mutation in high-risk group was observed in patients from TCGA NSCLC as well as GSE66836 cohort (Figure 5B), indicating NSCLC tumors with higher risk score were more susceptible to yielding DNA replication errors.